Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.
Scott Gottlieb, MD, will take on the new position “effective immediately.” UnitedHealth Group did not say what, if any, steering committee the former FDA lead will sit on.
Dubbed “Clearity,” the new health plans will have four tiers to choose from, allowing patients to select the provider and services that are right for them. The insurance is similar to a concierge care model, but backed by a potentially larger network.
Krista Nelson made the official announcement on LinkedIn. She replaces Patrick Conway, MD, CEO of the broader Optum, who had held dual roles. Nelson has been with UnitedHealthcare since 2017.
The research fund aims to track the health of Americans for decades, with the intent of housing the long-term health information of 70% to 90% of the population.
ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.
The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.
A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.
Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.
Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.